Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Y-mAbs Therapeutics, Inc. Banner

Y-mAbs Therapeutics, Inc.

YMAB Stock Analysis

Page title

Section title

Breakdown
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-17.057m-19.161m-43.274m-81.028m-119.337m-55.275m-95.568m-21.427m
Depreciation & Amortization
0.0000.00029.000K166.000K396.000K782.000K839.000K735.000K
Change in Working Capital
3.353M2.745M-47.000k2.665M3.444M-7.284m-10.371m-19.734m
Operating Cash Flow
-11.166m-15.870m-41.229m-73.497m-91.231m-102.556m-75.921m-27.232m
Capital Expenditure
0.0000.000-234.000k-1.965m-175.000k-967.000k0.0000.000
Free Cash Flow
-11.166m-15.870m-41.463m-75.462m-91.406m-103.523m-75.921m-27.232m
Debt Repayment
0.0000.0000.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
19.338M89.844M99.765M134.704M2.004M107.725M84.000K100.000K
Common Stock Repurchased
-366.000k0.0000.0000.0000.0000.0000.0000.000
Net Change in Cash
7.806M73.608M57.356M59.265M-92.502m66.930M-75.802m-27.125m